by Daniela Castim (Bio Market Insights) IBioIC, a Scottish Government-backed innovation centre focused on accelerating advances in the biotechnology sector has signed a collaboration deal with longstanding British counterpart Discovery Park.
Based in Kent, the Discovery Park development facility has been in operation since the 1950s and is home to organisations including Pfizer, Centauri Therapeutics and Concept Life Sciences.
On the other hand, Scotland’s Industrial Biotechnology Innovation Centre (IBioIC), is one of seven innovation centres launched with Scottish Government backing in 2012 and aims to foster collaboration between industry, academia and government.
The goal is to create opportunities for organisations operating at both locations and to enable Discovery Park, which is known for its work on drug discovery and manufacture, to develop its focus on industrial biotechnology, which offers a green alternative to fossil fuels. READ MORE